Amphotericin B - Nanomerics

Drug Profile

Amphotericin B - Nanomerics

Alternative Names: METAmphizon; NM-0147

Latest Information Update: 10 Aug 2016

Price : $50

At a glance

  • Originator Nanomerics
  • Class Antifungals; Antiprotozoals; Macrolides
  • Mechanism of Action Cell membrane permeability enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Leishmaniasis

Most Recent Events

  • 10 Aug 2016 Chemical structure information added
  • 28 Jul 2016 Phase-I clinical trials in Leishmaniasis in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top